Biotheus' manufacturing base is currently under construction and will be completed in two different phases. Phase I invovles the construction of 10 x 2000L production lines. Construction and product quality standards shall be in compliance with international regulations. This site will eventually support the commercial manufacturing of biologic products, including antibodies, recombinant proteins, and cell therapies.